RxDoctor Payments Data

Armando Ropero-Cartier, MD

Family Medicine · Miami, FLNPI 1851372825

Payments from drug & device makers

$63,042in general payments, 2019–2025

Across 25 payments — averaging $2521.70 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • GSK$35K
  • Janssen Research & Development, LLC$27K
  • Amgen$570
  • Nestle Healthcare Nutrition Inc.$31
  • Astellas Pharma US Inc$20
  • Pfizer$20
  • plus $13 from 1 others

What the payments were for

  • Food & beverage$84100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

20
21
22

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$63,042 in reported general payments places this provider in the 95th percentile of 7,282 family medicine providers in Florida.

See all family medicine providers in Florida

Medicare billing

Part B allowed, 2024
$148,763
Medicare patients
171
Services billed
2,001

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
EliquisApixaban186$134,100
ZenpepLipase/Protease/Amylase69$115,697
LinzessLinaclotide118$105,686
EntrestoSacubitril/Valsartan40$45,135
NuedextaDextromethorphan Hbr/Quinidine19$34,892
Diclofenac Sodium137$30,864
XareltoRivaroxaban39$27,391
RestasisCyclosporine29$26,020
CreonLipase/Protease/Amylase23$25,229
TradjentaLinagliptin27$21,338
Restasis MultidoseCyclosporine29$20,670
Cyclosporine35$16,931
OzempicSemaglutide13$12,906
MyrbetriqMirabegron16$12,472
Breo ElliptaFluticasone/Vilanterol28$10,981

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
PfizerEliquis$20$134,100186 claims
Astellas Pharma US IncMyrbetriq$20$12,47216 claims
GSKBreo Ellipta$35,225$10,98128 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 95th percentile of 7,282 family medicine providers in Florida.

Other family medicine in Miami

See the full list for Florida

Where these figures come from

Is this you, or does something look wrong? →